| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent t-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | activator |
| trimebutine | voltage-dependent t-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | activator |
| trimebutine | voltage-dependent t-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | activator |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | voltage-dependent l-type calcium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| trimebutine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| trimebutine | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| trimebutine | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | antagonist |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | calcium-activated potassium channel | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| trimebutine | mu-type opioid receptor | small molecule | NA | drugbank | Irritable Bowel Syndrome[MeSHID:D043183] Operative Surgical Procedures[MeSHID:D013514] Paralytic Ileus[MeSHID:D007418] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
| click here to return to the previous page | ||||||||